Study wrapper · #955
A single-centre, prospective, qualitative analysis of knowledge, attitudes and behaviour of sunbed use among patients attending a pigmented lesion clinic.
Lai FY, Quigley C, Murray G, et al. Skin health and disease. 2025.
DOI: 10.1093/skinhd/vzaf014PubMed: 40584950
Editor's note
This qualitative survey of sunbed users documents concurrent use of unregulated Melanotan I and II among tanning-focused patients and flags associated public-health risks such as blood-borne infection from injectable use. The peptides are examined as part of tanning behavior rather than for physiological effect. It offers useful real-world context on unregulated melanotan use.
Plain-language abstract
A survey of sunbed users at a dermatology clinic found that many also used unregulated tan-enhancing agents such as Melanotan I and II, raising concerns including blood-borne infection risk.
Related coverage
Weak / none
Five primary melanomas in situ in a patient with recent tanning bed use, melanotan exposure, and anabolic hormone use.
JAAD case reportsn=——2026
Weak / none
Unregulated Melanotan Use Promoted via Social Media: Emerging Dermatologic and Public Health Risks.
International journal of dermatologyn=——2026
Weak / none
Depigmented Facial and Neck Patches Following Melanotan Use in a Patient With Atopic Dermatitis and Alopecia Areata.
Clinical and experimental dermatologyn=——2026